Huadong Medicine Co., Ltd (SHE:000963)
27.90
+0.21 (0.76%)
Jun 9, 2026, 3:04 PM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 48.93 billion as of June 9, 2026. Its market cap has decreased by -25.75% in one year.
Market Cap
48.93B
Enterprise Value
47.71B
Revenue
44.06B
Ranking
n/a
PE Ratio
13.97
Stock Price
27.90
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 48.93B, an increase of 1,062.11%. That is a compound annual growth rate of 10.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 48.56B | -29.65% |
| Dec 31, 2025 | 69.03B | 14.00% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 87.65B |
| Yunnan Baiyao Group Co.,Ltd | 87.09B |
| Shanghai Fosun Pharmaceutical (Group) | 53.80B |
| China Resources Sanjiu Medical & Pharmaceutical | 40.29B |
| Shenzhen Salubris Pharmaceuticals | 35.99B |
| Beijing Tongrentang | 34.33B |
| Dong-E-E-Jiao | 31.86B |
| Humanwell Healthcare (Group) | 28.43B |